首页>
外国专利>
Prognosis evaluation method for prostate cancer patients based on microRNA
Prognosis evaluation method for prostate cancer patients based on microRNA
展开▼
机译:基于microRNA的前列腺癌患者预后评价方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present application concerns a new in vitro method for assessing the prognosis of a prostate cancer patient, comprising measuring the expression level of at least two miRs selected from group of miRs consisting of: miR-106a-5p, miR-10b-5p, miR-133a-3p, mi R-152-3p, miR-185-5p, miR-193a-5p, miR-221-3p, miR-23a-3p, miR-30d-3p, miR-326, mi R-374b-5p, miR-615-3p and mi R-625-3p in a RNA sample from prostate cells obtained from said patient, wherein a changed expression level of said at least 2 miRs, as compared to a reference expression profile, is indicative of the prognosis of said prostate cancer patient.
展开▼